Business Context and Reporting Period
Company: Ocular Therapeutix, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 8, 2022
Reporting Period: Second quarter ended June 30, 2022
Context: This filing serves to announce the financial results for the quarter ended June 30, 2022. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references the announcement of financial results but does not contain the specific numerical data within the body of this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Note: Specific financial figures are located in Exhibit 99.1 (Press Release), which is incorporated by reference but not included in the input text.
Material Changes
The filing text does not provide specific data to compare against the prior comparable period. It only confirms that results for the quarter ended June 30, 2022, were announced.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the full text of the press release containing management commentary and results is furnished as Exhibit 99.1.
Legal Disclaimer: The information in this Current Report, including Exhibit 99.1, is furnished to comply with Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 8, 2022) for actual revenue, net loss, and cash position figures.
- Verify the specific details of the "Results of Operations" referenced in Item 2.02.
- Confirm the company's status as an emerging growth company (indicated as checked in the filing).
- Check the Nasdaq Global Market listing status for Common Stock (Symbol: OCUL).